Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02138396 · ClinicalTrials.gov registry record · NA
Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions
A NA study, sponsored by INSYS Therapeutics.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02138396: Completed NA study, sponsored by INSYS Therapeutics.
NCT02138396 is a NA study that has completed, run by INSYS Therapeutics. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02138396, a NA study, has completed, sponsored by INSYS Therapeutics.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.
Interventions
- DRUG Naltrexone
- DRUG Fentanyl Sublingual Spray (FSS)
- DRUG Fentanyl Citrate Injection (FCI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT02138396 record still lists
NCT02138396 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Naltrexone is the first listed.
NCT02138396 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02138396 about?
NCT02138396 is a clinical study titled "Exploratory Bioavailability of Fentanyl Sublingual Spray Under Fasting Conditions". The objective of this study is to compare the rate of absorption and bioavailability of fentanyl sublingual spray 400 mcg to fentanyl citrate 100 mcg by intramuscular injection.
What is the current status of trial NCT02138396?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2014-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02138396?
The interventions under investigation include: Naltrexone (DRUG), Fentanyl Sublingual Spray (FSS) (DRUG), Fentanyl Citrate Injection (FCI) (DRUG).
Who is sponsoring clinical trial NCT02138396?
This trial is sponsored by INSYS Therapeutics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02138396's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia